Gilead Sciences and Renown Institute for Health Innovation Announce Strategic Collaboration to Advance Understanding of Nonalcoholic Steatohepatitis (NASH)

July 11, 2019

Gilead Sciences, Inc. (Nasdaq: GILD) and the Renown Institute for Health Innovation (IHI) today announced a strategic collaboration to collect and analyze genetic and electronic health data that can enhance the understanding of nonalcoholic steatohepatitis (NASH) and potentially inform development of treatment options for the disease. Under the terms of the collaboration and license agreement, Gilead will provide funding to Renown IHI to sequence and analyze the DNA of 15,000 individuals living with NASH or nonalcoholic fatty liver disease (NAFLD) as well as a control cohort of 40,000 individuals in Nevada.

“Combining the sequencing of protein coding DNA, with extensive electronic health record data will enable a deep analysis of the roles of genetics and environment in NASH incidence and progression,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “The analysis of these large datasets in collaboration with Renown IHI could help identify genetic variants that impact the risk of developing NASH and thereby advance the discovery and development of new treatments for this disease.”

Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools.

The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has 40,000 participants. “Combining genetic sequencing with large sets of data can play a critical role in understanding and identifying serious health risks, including diseases like NASH.

We are excited to collaborate with Gilead to better understand the condition and its complexities,” said Anthony Slonim, MD., DrPH. “Any genetic variants identified in participants through the collaboration may be shared with the participants for patient care purposes.”

About NASH

Nonalcoholic steatohepatitis (NASH) is a chronic form of liver disease characterized by excess fat in the liver, inflammation, and liver cell damage. Inflammation and liver cell damage can cause scarring of the liver, or fibrosis, and ultimately lead to cirrhosis or liver cancer. NASH is more common in people with certain conditions, including obesity and type 2 diabetes. There are currently limited approved treatments for patients living with NASH.

About Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.

About Renown Health

Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown Health’s commitment has extended beyond traditional health care to include community health and well-being. Renown Health works to improve health care through science, research and genetics; forge community partnerships that improve lives and develop innovative models that are improving health care in Nevada. For more information, visit renown.org.

About Helix

Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Powered by their proprietary Exome+™ assay—a panel-grade exome enhanced by more than 300,000 informative non-coding regions—Helix offers health systems a scalable solution which enables the discovery of medically relevant, potentially life-saving, genetic information. Additionally, Helix offers a suite of DNA-powered products for continued individual engagement and discovery.

Helix is headquartered in the San Francisco Bay Area and has one of the world’s largest CLIA-certified, CAP-accredited Next Generation Sequencing labs, located in San Diego, California. Learn more at www.helix.com.

Helix, the Helix logo, and Exome+ are trademarks of Helix Opco, LLC.

Gilead Forward-Looking Statement

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this collaboration, and Gilead may fail to discover, develop and commercialize any product candidates for the treatment of NASH. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements.

These and other risks are described in detail in Gilead’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, as filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Additional Media Contact:

Sung Lee, Investors 650-524-7792

Arran Attridge, Media 650-425-8975

Related News

Renown Health Welcomes Dr. Anathea C. Powell to Colon & Rectal Surgery Team

Providing Access to the Latest Advances in Surgery and Comprehensive Multidisciplinary Care

Nevada Governor Joe Lombardo and Renown President and CEO Dr. Brian Erling pose for a photo as Dr. Erling accepts his Governor's Award.

Dr. Brian Erling and Renown Health Honored with Governor's Award for Pioneering First Kidney Transplant Program for Northern Nevada by Nevada Donor Network

Dr. Brian Erling, President and CEO of Renown Health, has been awarded the prestigious 2025 Governor’s Award in recognition of his visionary leadership and instrumental role in establishing the first kidney transplant program for northern Nevada. Presented at the annual Nevada Donor Network Gala by Governor Joe Lombardo at his residence in Carson City on May 8, the Governor’s Award honors individuals who have made outstanding contributions to organ, eye, and tissue donation in the state. Dr. Erling’s efforts mark a historic first for healthcare in northern Nevada, giving residents access to lifesaving transplant care close to home for the first time. “I have the distinct pleasure on behalf of the Nevada Donor Network, the great state of Nevada and myself to award the 2025 Governor’s Award to Dr. Brian Erling of Renown Health,” said Governor Joe Lombardo. Joe Ferreira, president and CEO of the Nevada Donor Network, added his congratulations. “This is a momentous step forward for our state and provides hope and healing to those awaiting transplants and their families. The expansion of essential transplantation services across our state is made possible because of an extraordinary partnership. Thank you, Dr. Erling, for paving the way for better health outcomes and a brighter future for those in need.” Dr. Erling accepted the award, saying, “Many people in this room tonight worked long and hard to bring the Renown Transplant Institute® to our region, and are so deserving of this award. I am happy, on their behalf, to accept this award. I started my healthcare career as an emergency medicine physician and sometimes had to tell families about a loved one's death. I vowed to preserve the legacy of those patients if given the chance.” He added, “When I came to Renown from Colorado, one of the first questions I asked was, with the dramatic growth in our population in northern Nevada, are we able to make additional investments in expertise and clinical programs to help keep more care local? Increasing access to health care, both preventive care and advanced treatment—is critical for a community’s well-being and optimal health.” “As a team, we thought it would be incredible if we could bring a transplant program to our area. Just think about how many people have had to travel more than four hours out of the area and rent hotel rooms for weeks. Not every person can afford that. We think about things like that because at Renown Health, we care for everyone. When people have to travel to Vegas, or Salt Lake City or California, to get the care that they need, that is a health equity issue.” “So, we stepped in, and transplant became a top priority for the entire team. We have amazing people who have made this happen. Dr. Ernesto Molmenti has 25 years of transplant experience and came from Northwell Health in New York City to help lead this program. Dr. David Mulligan, also a transplant surgeon, comes to Renown from Yale and the Mayo Clinic. Ashley Cardenas, the administrator for the Renown Transplant Institute joins us from University of California, San Diego- School of Medicine. We have recruited some amazing people.” “And here at Renown, we have so many outstanding leaders who made this happen. From Chris Nicholas, our CEO at Renown Regional Medical Center, to Dr. Rahul Mediwala, CEO of our medical group and a nephrologist who has spent years planning for this program, to Jimmy Lao, director of nursing for our Emergency Rooms, to Taralynn Basham, director of nursing for our ICUs, and everyone in between- we say, “thank you!” He finished by saying, “Thank you for the honor. We are excited to get the Renown Transplant Institute up and running, and we are looking to do our first kidney transplant within the next several weeks. Thank you, Governor, for making healthcare a priority. It has been a pleasure working with you and your administration.” Assessments Now Open for Kidney Transplant Candidates The Renown Transplant Institute® at Renown Regional Medical Center in Reno is one of only 250 transplant centers nationwide and one of only two centers in all of Nevada. The Renown team is working closely with local healthcare providers and social workers at area dialysis centers to streamline referrals and ensure a smooth transition for patients to the transplant list. The Renown Transplant Institute is now accepting referrals for kidney transplant. Candidates will undergo a thorough evaluation process to determine their eligibility and readiness for a transplant. Physicians may now refer patients, or people with end-stage kidney disease who wish to be screened for a kidney transplant by Dr. Narisorn Atsava-Svate and Dr. Ernesto Molmenti, to call 1-833-RING-NTI (746-4684). For more information visit https://www.renown.org/locations/renown-transplant-institute and https://www.nvtransplant.org/. It is anticipated that the first kidney transplant surgeries will take place by July. To join the fight, donate to the Renown Health Foundation, a non-profit organization registered with the State of Nevada and recognized by the IRS as a 501(c)(3) entity at www.renown.org/donate or 775-982-5545. As the region’s only Level 2 Trauma Center for adults and children, Renown serves over 1 million people and 100,000 square miles. In U.S. News and World Report Best Hospital Rankings, Renown Regional Medical Center is named #1 Hospital for the State of Nevada for 2024, 2023 and 2022.

Renown Health ICUs Earn Prestigious Beacon Awards for Excellence, 3 Times in Row; Progressive Care Telemetry Unit First Time Winner

National recognition for critical care, intensive and progressive care nurses and units serving as role models for excellent patient and family care The American Association of Critical-Care Nurses (AACN) has recognized Renown Health Intensive, Critical Care and Progressive Care Units (ICUs, CCUs, PCUs) with Beacon Awards for Excellence®. Renown Health is among the few organizations in the U.S. to achieve this distinction three times in a row. In addition, Renown Regional Medical Center’s Telemetry Unit has been honored with the Beacon Award, ® marking the first time this dedicated team has achieved Beacon status. The Beacon Award for Excellence®, a significant milestone on the path to exceptional patient care and healthy work environments, recognizes unit caregivers who successfully improve patient outcomes and align practices with AACN’s six Healthy Work Environment Standards. Units that achieve this three-year award designations meet national criteria consistent with the ANCC Magnet Recognition Program®, the Malcolm Baldrige National Quality Award and the National Quality Healthcare Award. “These dedicated healthcare professionals join our exceptional community of nurses, who set the standard for optimal patient care,” said AACN President Jennifer Adamski, DNP, APRN, ACNP-BC, CCRN, FCCM. “I applaud the commitment of the caregivers at Renown Health for working together to meet and exceed the high standards set forth by the Beacon Award for Excellence®.” “Earning the Beacon Award for Excellence once is a remarkable achievement- but receiving it three times in a row is truly extraordinary,” said Brian Erling, MD, MBA, President and CEO, Renown Health. This honor reflects the unwavering dedication, sustained performance and a relentless focus on quality and patient safety by our ICU nurses, critical care, intensive and progressive care physicians, and care teams who bring clinical excellence and compassionate care to the bedside every day. We are incredibly proud of their work and honored to be among the few organizations nationwide to achieve this distinction multiple times.” Renown Health is among a select group of health systems nationwide with multiple Beacon-recognized ICUs, underscoring its role as the region’s Trauma Center and a leader in critical care. The four Beacon Awardees for Excellence ® for 2024 at Renown Regional Medical Center include:

View All Press Releases